Anterix ATEX Contingent consideration fair value adjustments

Contingent consideration fair value adjustments at other companies

Concentrix CorporationCNXC

——

Other financials

Income statement

See full

Revenue$2.0M+41.0%

Gross profit$608.0K+81.5%

Operating income$19.8M—

Net income$18.5M—

EPS (diluted)$0.98—

Balance sheet

See full

Cash & equivalents$98.5M+108%

Total debt$4.4M-18.0%

Total equity$262.3M+67.5%

Total assets$465.2M+39.7%

Cash flow

See full

Operating cash flow$15.5M+194%

CapEx$22.0K-52.2%

Free cash flow$15.5M+193%

Valuation

See full

Market cap$1.5B+190%

Enterprise value$1.4B+196%

P/E16.5×—

P/S230.1×+145×

Profitability

See full

Gross margin-105.3%—

Operating margin1,444.9%—

Net margin1,394.2%—

FCF margin-486.7%-1,481pp

Returns & leverage

See full

Return on equity43.3%—

Debt / equity0×0.0×

Current ratio3.3×+1.1×

Where this comes from

Reported directly by Anterix in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Anterix’s 10-Q, filed November 12, 2025, on SEC EDGAR. View the filing →

Ask your AI about Anterix's contingent consideration fair value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Anterix's contingent consideration fair value adjustments?: Anterix (ATEX) reported contingent consideration fair value adjustments of $6.37M in Q3 2025.